ACCELERON PHARMA INC COMMON S (XLRN) Covered Calls

ACCELERON PHARMA INC COMMON S covered calls Acceleron Pharma Inc discovers, develops, manufactures and commercializes novel protein therapeutics for orphan diseases and cancer. Its product line encompasses three clinical stage protein therapeutic candidates - Sotatercept, ACE-536 and Dalantercept.

You can sell covered calls on ACCELERON PHARMA INC COMMON S to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for XLRN (prices last updated Mon 4:16 PM ET):

ACCELERON PHARMA INC COMMON S (XLRN) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
58.02 +1.36 58.02 58.02 573K - 2.6B
Covered Calls For ACCELERON PHARMA INC COMMON S (XLRN)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Oct 19 60 1.30 56.72 2.3% 32.3%
Nov 16 60 2.70 55.32 4.9% 33.1%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Acceleron Pharma, Inc. is a clinical stage biopharmaceutical company. It is focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA.